[关键词]
[摘要]
目的: 构建肝癌细胞特异性小鼠IL1β反义RNA表达载体,观察其对H22肝癌细胞小鼠移植瘤生长的影响及其相关机制。方法:构建由AFP最小启动子和CMV增强子嵌合序列调控的携IL1β反义RNA表达载体pafpIRES2antiIL1β1和pafpIRES2antiIL1β2,经质粒PCR、限制性酶谱分析、序列测定进行鉴定。反义RNA表达载体转染小鼠H22肝癌细胞,分H22/mock组、H22/antiIL1β1组、H22/antiIL1β2三组,RTPCR检测IL1β的表达水平。以转染后的H22细胞皮下接种建立荷肝癌小鼠模型,观察移植瘤体积和重量,MTT法检测荷瘤小鼠脾脏中分离的NK细胞对H22细胞的杀伤活性。〖HT5W〗结果: 〖HT5"SS〗 经质粒PCR、限制性酶谱分析、序列测定证实成功构建能够在肝癌细胞中特异性表达IL1β反义RNA的表达载体pafpIRES2antiIL1β1和pafpIRES2antiIL1β2,转染H22细胞后细胞中IL1β表达水平明显下降,以pafpIRES2antiIL1β2更为显著。成功建立荷肝癌小鼠模型,与H22/mock组小鼠相比, H22/antiIL1β2组小鼠移植瘤体积较小,生长显著减慢(P<0.05)。 H22/antiIL1β1、H22/antiIL1β2组荷瘤小鼠的NK细胞对H22细胞的杀伤活性明显增强(P<0.05或P<0.01)。结论: 成功构建的肝癌细胞特异性IL1β反义RNA表达载体可有效抑制小鼠移植肝癌的生长,其机制与靶向阻断IL1β表达、上调NK细胞的杀伤活性有关
[Key word]
[Abstract]
Objective :To construct hepatocarcinoma specific IL1β antisense RNA expression vector and to explore its effect on the growth of implanted hepatocarcinoma H22 cells in mice and the possible mechanism. Methods: Murine IL1β antisense RNA expression vectors pafpIRES2antiIL1β1 and pafpIRES2antiIL1β2 under the regulation of minimal alphafeto protein (AFP) promoter and CMV enhancer were constructed, and further verified by PCR, restriction endonuclease analysis and DNA sequencing. H22 cells transfected with pafpIRES2antiIL1β 1 or pafpIRES2antiIL1β 2 were divided into 3 groups: H22/mock, H22/antiIL1β1 and H22/antiIL1β2 group. Expression of IL1β was detected by RTPCR. Transfected H22 cells were subcutaneously injected into mice to establish tumor implanted mouse model. Tumor volume was measured; the cytotocixity of spleen NK against H22 cells was detected by MTT. Results: Hepatocarcinoma specific IL1β antisense RNA expression vectors pafpIRES2antiIL1β1 and pafpIRES2antiIL1β2 were successfully constructed and were verified by PCR, restriction endonuclease analysis and DNA sequencing. IL1β expression in H22 cells was downregulated after transfected with IL1β antisense RNA expression vectors, especially with the pafpIRES2antiIL1β2 vector. Hepatocarcinoma cells implanted mouse model was successfully established. Tumor volume and growth of tumor in H22/antiIL1β2 mice was obviously smaller than that in H22/mock mice, and the cytotocixity of spleen NK against H22 cells in H22/antiIL1β1 and H22/antiIL1β2 mice was also greatly enhanced. Conclusion: Hepatocarcinoma specific IL1β antisense RNA expression vector pafpIRES2antiIL1β was successfully constructed. It effectively inhibits the growth of implanted hepatocarcinoma in mice probably through specifically blocking expression of IL1β and increasing cytotocixity of spleen NK.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No.30772497);山东省高层次卫生人才1020工程专项基金;教育部科学技术研究基金重点项目(No.205090);山东省科技攻关计划项目(No.2008GG10002007)